Quick-Med Technologies, Inc. - Financial Analysis Review

Quick-Med Technologies, Inc. - Financial Analysis Review

Summary

Quick-Med Technologies, Inc. (Quick-Med) is a life sciences company, engaged in the research, development and commercialization of biomedical products for consumer, industrial, and healthcare markets. It has been focusing on the development of four proprietary technologies, namely, Novel Intrinsically Micro Bonded Utility Substrate (NIMBUS), Stay Fresh, NimbuDerm and MultiStat family of technologies. Its technologies are also used for advanced military and civilian medical applications. The company focuses on the research and development activities to develop its proprietary technologies soon for its industrial partners.

Global Markets Direct’s "Quick-Med Technologies, Inc. - Financial Analysis Review” is an in-depth business and financial analysis of Quick-Med Technologies, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the financial analysis of the company. This highlights the company’s ratio analysis for the past five years.

And More inside the report…

Recent Developments

Nov 17, 2009: Quick-Med Announces First Royalty Payments For Its Novel NIMBUS Technology
Jul 28, 2009: Lansdowne Stops Investments In Flagship Fund

Scope

- Provides key company information for business intelligence needs
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last fourinterim periods.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

- A quick “one-stop-shop” to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with insight into the companies’ financial performance.

Report Highlights

The following companies are the major competitors of Quick-Med Technologies, Inc.:
Ciba Specialty Chemicals Holding Inc.
The Dow Chemical Company
Milliken & Company
Agion Technologies, Inc.
Nucryst Pharmaceuticals Inc.
Microban International, Ltd.
[Studien Infos ausblenden]

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Quick-Med Technologies, Inc. - Key Facts 4
Quick-Med Technologies, Inc. - Business Description 4
Quick-Med Technologies, Inc. - Major Products and Services 5
Quick-Med Technologies, Inc. - History 6
Quick-Med Technologies, Inc. - Key Competitors 8
Quick-Med Technologies, Inc. - Key Employees 8
Quick-Med Technologies, Inc. - Key Employee Biographies 9
Quick-Med Technologies, Inc. - Company Statement 10
Quick-Med Technologies, Inc. - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Quick-Med Technologies, Inc. - Financial Ratios 12
Financial Ratios - Capital Market Ratios 12
Financial Ratios - Annual Ratios 12
Financial Ratios - Interim Ratios 13
Financial Ratios - Ratio Charts 14
Recent Developments 15
Corporate Communications 15
Sep 11, 2007: QMTI Appoints New Board Member 15
Aug 09, 2007: QMTI Appoints New CEO 15
Jan 09, 2006: QMTI Appoints New Board Member 15
Product News 16
Nov 16, 2009: Quick-Med Announces First Royalty Payments For Its Novel NIMBUS Technology 16
Oct 23, 2009: Quick-Med Announces Guidance From FDA To Support The Classification Of The NIMBUS Barrier Gauze Wound Dressings As Class II Medical Devices 16
Mar 03, 2009: Quick-Med Receives Additional Patent For NIMBUS 17
Feb 26, 2009: Quick-Med Technologies Receives FDA Clearance For NIMBUS 17
Nov 18, 2008: New Study Reaffirms Quick-Med’s NIMBUS Technology Poses No Threat Of Bacterial Resistance 18
May 14, 2008: NimbuDerm Receives Wound Healing Society's Prestigious Blue Ribbon Award 18
Feb 08, 2007: Mexico Grants Quick-Med Technologies Notice Of Allowance For Its Nimbus Technology 19
Nov 15, 2005: Quick-Med Technologies, Inc. Awarded U.S. Army SBIR Phase I Contract 19
Product Approvals 19
Feb 26, 2009: Quick-Med Technologies Receives FDA Clearance For NIMBUS 19
Clinical Trials 19
Nov 18, 2008: New Study Reaffirms Quick-Med’s NIMBUS Technology Poses No Threat Of Bacterial Resistance 20
Other Significant Developments 20
Apr 02, 2007: QMTI Signs License Agreement With DSI 20
Feb 12, 2008: QMTI Moves Its R&D Center To Florida 21
Strategy and Business Planning 21
Jul 28, 2009: Lansdowne Stops Investments In Flagship Fund 21
Appendix 22
Methodology 22
Ratio Definitions 22
About Global Markets Direct 25
Contact Us 25
Disclaimer 25
[Inhaltsverzeichnis ausblenden]

List of Tables
Quick-Med Technologies, Inc., Key Facts 4
Quick-Med Technologies, Inc., Major Products and Services 5
Quick-Med Technologies, Inc., History 6
Quick-Med Technologies, Inc., Key Employees 8
Quick-Med Technologies, Inc., Key Employee Biographies 9
Quick-Med Technologies, Inc., Other Locations 11

List of Figures
Quick-Med Technologies, Inc., Performance Chart (2005 - 2009) 1
Quick-Med Technologies, Inc., Ratio Charts 14
[Tabellenverzeichnis ausblenden]